Color Health Partners With Evry Health to Expand Access to Virtual Cancer Care

Cancer care company Color Health is partnering with insurer Evry Health to enhance employer health plans with its cancer care services, according to a Wednesday announcement. Evry Health is a Texas-based insurer serving fully insured employers with 51 or more employees. Its plans have no traditional cost-sharing, including no co-pays and no deductibles, and provide…

Read More

Cartography Bio Corrals $67M to Bring Targeted Colorectal Cancer Drug Into the Clinic

Colorectal cancer patients whose disease exhibits certain rare genetic signatures have the option of treatment with immunotherapies. But these targeted cancer treatments haven’t worked for patients with the two subtypes that represent the majority of colorectal cancer cases. The technologies of Cartography Biosciences enable its scientists to find their way to the right targets for…

Read More

Merck’s Injectable Version of Blockbuster Cancer Drug Keytruda Wins FDA Approval

A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA approved, a regulatory decision that gives patients a less burdensome dosing option and provides the pharmaceutical giant a way to retain some market share as the original intravenously infused formulation — its top-selling product — faces patent expirations. The approval announced Friday covers…

Read More